ATE420890T1 - Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide - Google Patents

Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide

Info

Publication number: ATE420890T1
Authority: AT; Austria
Prior art keywords: threonyl; isoleucyl; asparaginyl; valyl; threonine
Prior art date: 2003-11-19

Application number

AT04798591T

Other languages

English (en)

Inventor

Wai Ming Wong

Kong Lam

Original Assignee

Cms Peptides Patent Holding Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-19

Filing date

2004-11-18

Publication date

2009-01-15

2004-11-18 Application filed by Cms Peptides Patent Holding Co filed Critical Cms Peptides Patent Holding Co

2009-01-15 Application granted granted Critical

2009-01-15 Publication of ATE420890T1 publication Critical patent/ATE420890T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
SZDPIBYLDKBMLK-XHLYJBQOSA-N (2s,3r)-2-[[(2s,3r)-2-[[(2s)-4-amino-2-[[(2s,3r)-2-[[(2s)-2-[[(2s,3s)-2-amino-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SZDPIBYLDKBMLK-XHLYJBQOSA-N 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT04798591T 2003-11-19 2004-11-18 Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide ATE420890T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US52383703P	2003-11-19	2003-11-19

Publications (1)

Publication Number	Publication Date
ATE420890T1 true ATE420890T1 (de)	2009-01-15

Family

ID=34632832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04798591T ATE420890T1 (de)	2003-11-19	2004-11-18	Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide

Country Status (9)

Country	Link
US (1)	US7396817B2 (de)
EP (1)	EP1689771B1 (de)
JP (1)	JP4614966B2 (de)
KR (1)	KR101258128B1 (de)
CN (1)	CN100434437C (de)
AT (1)	ATE420890T1 (de)
DE (1)	DE602004019141D1 (de)
ES (1)	ES2320899T3 (de)
WO (1)	WO2005051981A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2616525C (en) *	2005-07-26	2014-06-17	Cms Peptides Patent Holding Company Limited	Novel biologically active peptides and their new uses
US9616114B1 (en)	2014-09-18	2017-04-11	David Gordon Bermudes	Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en)	2015-05-11	2020-06-09	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en)	2016-12-07	2021-11-23	David Gordon Bermudes	Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en)	2016-12-07	2021-09-28	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
JP2025534393A (ja) *	2022-12-08	2025-10-15	ベイジン・ナンバー１・バイオ－テクノロジー・ディベロップメント・カンパニー・リミテッド	睡眠改善、うつ病予防もしくは治療、または腸機能改善におけるウシ脾臓ペプチド粉末の使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6436703B1 (en) *	2000-03-31	2002-08-20	Hyseq, Inc.	Nucleic acids and polypeptides

2004
- 2004-11-18 EP EP04798591A patent/EP1689771B1/de not_active Expired - Lifetime
- 2004-11-18 US US10/595,842 patent/US7396817B2/en not_active Expired - Fee Related
- 2004-11-18 DE DE602004019141T patent/DE602004019141D1/de not_active Expired - Lifetime
- 2004-11-18 CN CNB2004800324062A patent/CN100434437C/zh not_active Expired - Fee Related
- 2004-11-18 WO PCT/GB2004/004877 patent/WO2005051981A1/en not_active Ceased
- 2004-11-18 ES ES04798591T patent/ES2320899T3/es not_active Expired - Lifetime
- 2004-11-18 JP JP2006540593A patent/JP4614966B2/ja not_active Expired - Fee Related
- 2004-11-18 AT AT04798591T patent/ATE420890T1/de not_active IP Right Cessation
2006
- 2006-05-17 KR KR1020067009629A patent/KR101258128B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR101258128B1 (ko)	2013-05-06
JP2008500272A (ja)	2008-01-10
CN1875032A (zh)	2006-12-06
EP1689771A1 (de)	2006-08-16
US20060234943A1 (en)	2006-10-19
ES2320899T3 (es)	2009-05-29
CN100434437C (zh)	2008-11-19
DE602004019141D1 (de)	2009-03-05
WO2005051981A1 (en)	2005-06-09
JP4614966B2 (ja)	2011-01-19
KR20060103508A (ko)	2006-10-02
EP1689771B1 (de)	2009-01-14
HK1092162A1 (en)	2007-02-02
US7396817B2 (en)	2008-07-08

Similar Documents

Publication	Publication Date	Title
EP1778842B8 (de)	2012-03-21	Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
EP1196184A4 (de)	2003-05-28	Verbindungen und methoden zur behandlung schneller funktionsstörungen
DE50004018D1 (de)	2003-11-13	Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
PL363071A1 (pl)	2004-11-15	Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
MXPA05008704A (es)	2005-10-05	Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
TR200103339T2 (tr)	2002-04-22	Geliştirilmiş çözülürlük özelliklerine sahip yeni LHRH-antagonistleri.
ATE420890T1 (de)	2009-01-15	Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
GB0203420D0 (en)	2002-04-03	Peptide
ATE474589T1 (de)	2010-08-15	Angiogene peptide und ihre verwendungen
GB0203419D0 (en)	2002-04-03	Peptide
DE50114335D1 (de)	2008-10-30	Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
JP2004533846A5 (de)	2008-06-26
SG142165A1 (en)	2008-05-28	Biologically active peptides
EP1557466A4 (de)	2006-02-08	Tumorantigenprotein und dessen verwendung
NZ591827A (en)	2012-10-26	Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE484290T1 (de)	2010-10-15	Peptid mit antitumoraler wirkung
RU2001105086A (ru)	2004-01-20	Новые пептиды для применения в иммунотерапии аутоиммунных заболеваний
PT1105503E (pt)	2005-03-31	Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada
DE60325227D1 (de)	2009-01-22
EP1372691A4 (de)	2005-11-09	Mucinpeptid mit immunstärkenden eigenschaften
WO2004011638A3 (en)	2004-07-01	Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
AU4956901A (en)	2001-10-08	Novel human 7tm proteins and polynucleotides encoding the same
IL150045A0 (en)	2002-12-01	Compositions and methods for detecting stress-inducible proteins
NZ509284A (en)	2003-03-28	Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call

Legal Events

Date	Code	Title	Description
2009-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties